News and events

Creative states: Is state-led risk-taking the answer to post-Covid-19 recovery?

28 April 2021

Writing in the RSA Journal, Innogen Director, Theo Papaioannou, examines how the entrepreneurial state could work in practice.

Local manufacturing for health in Africa

22 April 2021

Geoffrey Banda, Dinar Kale, Maureen Mackintosh, and Innogen Associate Julius Mugwagwa have authored a report from a webinar in which invited stakeholders from the  African and Indian pharmaceutical sectors as well as academia reflected on the immediate experience of manufacturing for health under Covid-19 conditions on the African continent.

Joyce Tait delivers keynote presentation at Bloomsbury SET conference

18 March 2021

Innogen co-director Joyce Tait gave a keynote presentation at the virtual Bloomsbury SET conference focused on infectious diseases and antimicrobial resistance. Her talk in the first session of the conference: “Interdisciplinary knowledge exchange to tackle global health challenges” highlighted some of the Innogen’s work on regulatory adaptation to support the development of new antimicrobial drugs and rapid diagnostics.

Industry-wide standard supports companies to innovate responsibly

4 February 2021

Innogen Masters students trial the application of the British Standards Institution (BSI) Responsible Innovation Guide, PAS 440, in two early-stage biotechnology companies.

Innogen researchers speak out about the value and fair diffusion of COVID-19 vaccines

21 January 2021

Innogen researchers have been featured in national and international media outlets addressing some of the questions that the vaccine roll-out has raised.

PAS 440 — Responsible Innovation in the spotlight

15 December 2020

In the latest episode of the BSI EDUCATION PODCAST, Joyce Tait, technical author of the standard PAS 440 explains how it was developed and its relevance for regulatory adaptation in the UK.

In Conversation event: Are innovation policies ever value neutral?

16 November 2020

Smita Srinivas & Theo Papaioannou in conversation with David Wield discuss innovation as a political process of development in the context of COVID-19.

Rapid diagnostic tests are no panacea for tackling antimicrobial resistance

5 November 2020

Innogen members Ann Bruce and Katie Adam have co-authored a paper as part of the Diagnostic Innovation and Livestock (DIAL) project team, in collaboration with the University of Exeter and Bristol Veterinary School. This new publication explores the potential role of rapid or point-of-care diagnostic tests for farm animals in supporting decisions about antimicrobial use in livestock.

European funding boosts production of animal feed made from recycled carbon

29 October 2020

Innogen researchers are working on a recycling project with Deep Branch Biotechnology that produces sustainable protein for animal feed from carbon dioxide. The company has recently secured European Innovation Council (EIC) Accelerator funding of €2.5 million to scale up production.

National COVID-19 testing strategy analysis

15 October 2020

Innogen member Smita Srinivas and co-authors analyse COVID-19 testing in different countries. They highlight the need to take the industrial organisation of health systems within countries into account for testing strategies to be successful.